Perrigo Company plc (PRGO)
NYSE: PRGO · IEX Real-Time Price · USD
25.99
-0.26 (-0.99%)
At close: Jul 2, 2024, 4:00 PM
24.75
-1.24 (-4.77%)
After-hours: Jul 2, 2024, 7:40 PM EDT
Perrigo Company Employees
Perrigo Company had 9,140 employees as of December 31, 2023. The number of employees increased by 240 or 2.70% compared to the previous year.
Employees
9,140
Change (1Y)
240
Growth (1Y)
2.70%
Revenue / Employee
$498,457
Profits / Employee
-$842
Market Cap
3.54B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 9,140 | 240 | 2.70% |
Dec 31, 2022 | 8,900 | -1,000 | -10.10% |
Dec 31, 2021 | 9,900 | -1,600 | -13.91% |
Dec 31, 2020 | 11,500 | 300 | 2.68% |
Dec 31, 2019 | 11,200 | 600 | 5.66% |
Dec 31, 2018 | 10,600 | 200 | 1.92% |
Dec 31, 2017 | 10,400 | -2,400 | -18.75% |
Dec 31, 2016 | 12,800 | -500 | -3.76% |
Dec 31, 2015 | 13,300 | 3,080 | 30.14% |
Jun 28, 2014 | 10,220 | 320 | 3.23% |
Aug 9, 2013 | 9,900 | 1,100 | 12.50% |
Aug 10, 2012 | 8,800 | 100 | 1.15% |
Aug 9, 2011 | 8,700 | 1,000 | 12.99% |
Aug 9, 2010 | 7,700 | 450 | 6.21% |
Aug 10, 2009 | 7,250 | 1,050 | 16.94% |
Aug 8, 2008 | 6,200 | 0 | - |
Jun 30, 2007 | 6,200 | 231 | 3.87% |
Jul 1, 2006 | 5,969 | 121 | 2.07% |
Jun 25, 2005 | 5,848 | 3,138 | 115.79% |
Jun 26, 2004 | 2,710 | -115 | -4.07% |
Jun 28, 2003 | 2,825 | -172 | -5.74% |
Jun 29, 2002 | 2,997 | -317 | -9.57% |
Jun 30, 2001 | 3,314 | -228 | -6.44% |
Jul 1, 2000 | 3,542 | -649 | -15.49% |
Jul 3, 1999 | 4,191 | -677 | -13.91% |
Jun 30, 1998 | 4,868 | 756 | 18.39% |
Jun 30, 1997 | 4,112 | 76 | 1.88% |
Jun 30, 1996 | 4,036 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Neogen | 2,640 |
Guardant Health | 1,779 |
Ultragenyx Pharmaceutical | 1,276 |
Alvotech | 1,026 |
Axonics | 797 |
Prestige Consumer Healthcare | 560 |
Axsome Therapeutics | 545 |
Crinetics Pharmaceuticals | 290 |
PRGO News
- 8 days ago - Notice of Proposed Settlement and Plan of Allocation Involving Purchasers of Perrigo Common Stock from April 21, 2015 through May 2, 2017 and Owners of Perrigo Common Stock as of November 12, 2015 - GlobeNewsWire
- 5 weeks ago - Perrigo to Attend Oppenheimer 24th Annual Consumer Growth & E-Commerce Conference - PRNewsWire
- 2 months ago - Perrigo Reports First Quarter 2024 Financial Results From Continuing Operations - PRNewsWire
- 2 months ago - Perrigo Announces Executive Transition for its Consumer Self-Care International (CSCI) Business - PRNewsWire
- 2 months ago - Perrigo Announces Quarterly Dividend - PRNewsWire
- 2 months ago - Perrigo Receives Binding Offer to Divest its HRA Pharma Rare Diseases Business for up to €275 Million - PRNewsWire
- 2 months ago - Perrigo to Release First Quarter 2024 Financial Results on May 7, 2024 - PRNewsWire
- 3 months ago - CVS Caremark to cover Perrigo's birth control pill in US at zero cost for plan sponsors - Reuters